Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Dombernowsky

Showing results (131-140 of 211) with videos related to

Pageof 22
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1995
Evaluation of the optimal duration of chemotherapy in phase II trials for inoperable non-small-cell lung cancer (NSCLC)H Larsen, J B Sorensen, A L Nielsen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1994
Phase II study of gemcitabine (2',2'-difluorodeoxycytidine) given as a twice weekly schedule to previously untreated patients with non-small cell lung cancerB Lund, M Ryberg, P M Petersen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Randomized, double-blind comparison of ondansetron versus ondansetron plus metopimazine as antiemetic prophylaxis during platinum-based chemotherapy in patients with cancerJ Herrstedt, T Sigsgaard, J Handberg, et al.
Scandinavian Journal of Haematology|January 1, 1974
The Radner needle a bone-marrow biopsy deviceP Dombernowsky, A M Worm, B Hainau, et al.
Cancer Chemotherapy Reports|September 1, 1975
Clinical trial of the oral form of a new podophyllotoxin derivative, VP-16-213 (NSC-141540), in patients with advanced neoplastic diseaseN I Nissen, H H Hansen, H Pedersen, et al.
Seminars in Oncology|December 1, 1995
Treatment of metastatic breast cancer with paclitaxel and doxorubicinP Dombernowsky, J Gehl, M Boesgaard, et al.
European Journal of Cancer|January 1, 1980
A phase III study of prednimustine (LEO 1031) in advanced breast cancer. A preliminary reportM Rørth, J Løber, P Dombernowsky, et al.
European Journal of Cancer (Oxford, England : 1990)|April 22, 1999
Doxorubicin versus methotrexate both combined with cyclophosphamide, 5-fluorouracil and tamoxifen in postmenopausal patients with advanced breast cancer--a randomised study with more than 10 years follow-up from the Danish Breast Cancer Cooperative Group. Danish Breast Cancer Cooperative Group (DBCG)M Andersson, E L Madsen, M Overgaard, et al.
Cancer|November 1, 1983
A phase III trial comparing prednimustine (LEO 1031) to chlorambucil plus prednisolone in advanced breast cancerJ Løber, H T Mouridsen, I E Christiansen, et al.
British Journal of Cancer|July 1, 1986
Chemotherapy versus chemotherapy plus irradiation in limited small cell lung cancer. Results of a controlled trial with 5 years follow-upK Osterlind, H H Hansen, H S Hansen, et al.
Pageof 22

Showing results (131-140 of 211) with videos related to

Sort By:
Pageof 22
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1995
Evaluation of the optimal duration of chemotherapy in phase II trials for inoperable non-small-cell lung cancer (NSCLC)H Larsen, J B Sorensen, A L Nielsen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1994
Phase II study of gemcitabine (2',2'-difluorodeoxycytidine) given as a twice weekly schedule to previously untreated patients with non-small cell lung cancerB Lund, M Ryberg, P M Petersen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Randomized, double-blind comparison of ondansetron versus ondansetron plus metopimazine as antiemetic prophylaxis during platinum-based chemotherapy in patients with cancerJ Herrstedt, T Sigsgaard, J Handberg, et al.
Scandinavian Journal of Haematology|January 1, 1974
The Radner needle a bone-marrow biopsy deviceP Dombernowsky, A M Worm, B Hainau, et al.
Cancer Chemotherapy Reports|September 1, 1975
Clinical trial of the oral form of a new podophyllotoxin derivative, VP-16-213 (NSC-141540), in patients with advanced neoplastic diseaseN I Nissen, H H Hansen, H Pedersen, et al.
Seminars in Oncology|December 1, 1995
Treatment of metastatic breast cancer with paclitaxel and doxorubicinP Dombernowsky, J Gehl, M Boesgaard, et al.
European Journal of Cancer|January 1, 1980
A phase III study of prednimustine (LEO 1031) in advanced breast cancer. A preliminary reportM Rørth, J Løber, P Dombernowsky, et al.
European Journal of Cancer (Oxford, England : 1990)|April 22, 1999
Doxorubicin versus methotrexate both combined with cyclophosphamide, 5-fluorouracil and tamoxifen in postmenopausal patients with advanced breast cancer--a randomised study with more than 10 years follow-up from the Danish Breast Cancer Cooperative Group. Danish Breast Cancer Cooperative Group (DBCG)M Andersson, E L Madsen, M Overgaard, et al.
Cancer|November 1, 1983
A phase III trial comparing prednimustine (LEO 1031) to chlorambucil plus prednisolone in advanced breast cancerJ Løber, H T Mouridsen, I E Christiansen, et al.
British Journal of Cancer|July 1, 1986
Chemotherapy versus chemotherapy plus irradiation in limited small cell lung cancer. Results of a controlled trial with 5 years follow-upK Osterlind, H H Hansen, H S Hansen, et al.
Pageof 22